BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6133036)

  • 1. Hepatic tyrosine aminotransferase in tyrosinaemia type II.
    Kida K; Takahashi M; Fujisawa Y; Matsuda H; Machino H; Miki Y
    J Inherit Metab Dis; 1982; 5(4):229-30. PubMed ID: 6133036
    [No Abstract]   [Full Text] [Related]  

  • 2. Tyrosinosis (tyrosinaemia).
    Jaiswal RB
    Indian Pediatr; 1975 Mar; 12(3):209-10. PubMed ID: 239906
    [No Abstract]   [Full Text] [Related]  

  • 3. A new variant form of hypertyrosinaemia due to 4-hydroxyphenylpyruvic acid oxidase deficiency.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    J Inherit Metab Dis; 1982; 5(4):237-8. PubMed ID: 6133038
    [No Abstract]   [Full Text] [Related]  

  • 4. Putative genetic deficiency of 4-hydroxyphenylpyruvic acid dioxygenase in mice: a murine model for hereditary tyrosinaemia type III.
    Endo F; Katoh H; Matsuda I
    J Inherit Metab Dis; 1990; 13(5):780-2. PubMed ID: 2246865
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of tyrosine aminotransferase and para-hydroxyphenylpyruvate dioxygenase activities in fetal and neonatal human liver.
    Ohisalo JJ; Laskowska-Klita T; Andersson SM
    J Clin Invest; 1982 Jul; 70(1):198-200. PubMed ID: 6123525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme defect in a case of tyrosinemia type I, acute form.
    Furukawa N; Kinugasa A; Seo T; Ishii T; Ota T; Machida Y; Inoue F; Imashuku S; Kusunoki T; Takamatsu T
    Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defect in soluble tyrosine aminotransferase in skin fibroblasts of a patient with tyrosinemia.
    deGroot GW; Dakshinamurti K; Allan L; Haworth JC
    Pediatr Res; 1980 Jul; 14(7):896-8. PubMed ID: 6106182
    [No Abstract]   [Full Text] [Related]  

  • 8. Tyrosinemia type III: diagnosis and ten-year follow-up.
    Cerone R; Holme E; Schiaffino MC; Caruso U; Maritano L; Romano C
    Acta Paediatr; 1997 Sep; 86(9):1013-5. PubMed ID: 9343288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parahydroxyphenylpyruvicacidemia in tyrosinosis.
    Jaiswal RB; Bhai I; Daginawala HF; Nath N; Nath MC
    Indian Pediatr; 1978 Nov; 15(11):893-9. PubMed ID: 36347
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic enzymes of tyrosine metabolism in tyrosinemia II.
    Goldsmith LA; Thorpe J; Roe CR
    J Invest Dermatol; 1979 Dec; 73(6):530-2. PubMed ID: 41876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New forms of hereditary tyrosinemia type II in mink: hepatic tyrosine aminotransferase defect.
    Christensen K; Henriksen P; Sørensen H
    Hereditas; 1986; 104(2):215-22. PubMed ID: 2876972
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful dietary control of tyrosinemia II.
    Machino H; Miki Y; Kawatsu T; Kida K; Matsuda H
    J Am Acad Dermatol; 1983 Oct; 9(4):533-9. PubMed ID: 6195199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal tyrosinaemia II: management and successful outcome.
    Francis DE; Kirby DM; Thompson GN
    Eur J Pediatr; 1992 Mar; 151(3):196-9. PubMed ID: 1350979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble tyrosine aminotransferase deficiency: an unusual cause of corneal ulcers.
    Burns RP
    Am J Ophthalmol; 1972 Mar; 73(3):400-2. PubMed ID: 4401188
    [No Abstract]   [Full Text] [Related]  

  • 15. Persistent tyrosinemia associated with low activity of tyrosine aminotransferase.
    Andersson S; Nemeth A; Ohisalo J; Strandvik B
    Pediatr Res; 1984 Jul; 18(7):675-8. PubMed ID: 6147810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Richner-Hanhart syndrome (oculocutaneous tyrosinaemia, tyrosinaemia type II).
    Paige DG; Clayton P; Bowron A; Harper JI
    J R Soc Med; 1992 Dec; 85(12):759-60. PubMed ID: 1362969
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical observations on so-called hereditary tyrosinemia.
    Gaull GE; Rassin DK; Solomon GE; Harris RC; Sturman JA
    Pediatr Res; 1970 Jul; 4(4):337-44. PubMed ID: 4393588
    [No Abstract]   [Full Text] [Related]  

  • 18. Perinatal development of the tyrosine oxidizing system.
    Coufalik A; Monder C
    Biol Neonate; 1978; 34(3-4):161-6. PubMed ID: 32931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological abnormalities in a patient with tyrosinaemia type III.
    D'Eufemia PD; Finocchiaro R; Celli M; Viozzi L; Giardini O
    J Inherit Metab Dis; 1995; 18(3):355-6. PubMed ID: 7474904
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of ketogenesis from amino acids. III. In vitro and in vivo studies on ketone body formation lipogenesis and oxidation of tyrosine by rats.
    Tanaka K; Ichihara A
    Biochim Biophys Acta; 1975 Aug; 399(2):302-12. PubMed ID: 240411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.